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background:  The results of PEGASUS trial, evaluating the effects of dual antiplatelet therapy in patients with prior AMI, will be presented 
during ACC2015. Whether the PEGASUS selection criteria adequately reflect long term risk of mortality in routine practice is questionable.
methods and Results:  FAST-MI is a nationwide French registry recruiting consecutive AMI patients in 213 centres. Out of 3059 AMI pts, 
2559 were alive and recurrent-MI-free at 1 yr. We evaluated the 4-year survival among this population classified into three groups: Gr 1 
(n=1552, 61%) meeting the PEGASUS inclusion (age >50 yrs, and ≥1 additional risk factor: age ≥65, diabetes, previous MI, non-end-stage 
chronic kidney disease, multivessel CAD) and exclusion (prior stroke, chronic anticoagulant medication, on dialysis) criteria; Gr 2 (n=761, 
30%) meeting neither the inclusion nor exclusion criteria; and Gr 3 (n=246, 10%) meeting the exclusion criteria.
Results:  Gr2 pts were younger than Gr1 or Gr3 pts, with a lower GRACE score, less comorbidity, and had more STEMI (Table). The 
4-year survival was 81% in Gr 1, 95% in Gr 2, and 63% in Gr 3 (P<0.001). Age was the most discriminant criteria of survival; 4-year survival 
was 96% in pts ≤50 yrs vs 81% in those >50 yrs and in pts >50 yrs, the major discriminant was age ≥65 (73.5% vs 93%).
conclusion:  Enrichment criteria used in PEGAGUS trial succeed in defining a high risk population among patients with prior heart attack. 
Most of the discriminating power, however, is carried by age only.
PEGASUS-like (G1) n=1552 Non-PEGASUS (Gr2) n=761
PEGASUS-excluded 
(Gr3)
N=246
Age (years) 72 ± 10 50 ± 8 72 ± 12
Age <50 years (%) 0 55 5
Age ≥65 years (%) 74 0 76
Women (%) 35 18 38
STEMI (%) 48 68 44
GRACE score 153 ± 31 117 ± 25 159 ± 34
CKD (%) 4 0.4 6.5
Diabetes (%) 28 4.5 34
